Categories: News

Cango Inc. Completes US$65 Million Strategic Investment and Secures US$10 Million Convertible Note Financing to Strengthen Financial Position and Drive AI and Energy Expansion

DALLAS, April 1, 2026 /PRNewswire/ — Cango Inc. (NYSE: CANG), a leading Bitcoin miner leveraging its global operations to develop an integrated energy and AI compute platform, today announced two significant capital transactions: the closing of a US$65.0 million strategic investment from members of Company leadership, and the execution of a US$10.0 million convertible note financing agreement with DL Holdings Group Limited (HKEX: 1709) (“DL Holdings”), a Hong Kong-listed financial services group. The Company and DL Holdings have also entered into a memorandum of understanding (“MOU”) establishing a strategic cooperation framework.

- Advertisement -

Closing of US$65.0 Million Strategic Investment

- Advertisement -

Pursuant to the definitive investment agreements previously announced on February 12, 2026, the Company issued and sold an aggregate of 49,242,424 Class A ordinary shares to two entities, each wholly-owned by Mr. Xin Jin, Chairman of the Company’s board of directors, and Mr. Chang-Wei Chiu, a director of the Company, respectively. The transaction closed on March 31, 2026, generating net proceeds equivalent to US$65.0 million, settled in USDT, reinforcing the Company’s capital structure and reflecting leadership’s confidence in its strategic direction.

- Advertisement -

US$10 Million Convertible Note Financing and Strategic Partnership with DL Holdings

- Advertisement -

The Company entered into a securities purchase agreement with DL Holdings. Pursuant to the SPA, the Company issued and sold to DL Holdings a US$10,000,000 convertible note and a warrant to purchase up to 370,370 Class A ordinary shares at an exercise price of US$2.70 per share. Proceeds are intended for upstream acquisitions and expansion into AI and computing infrastructure.

- Advertisement -

The note matures on April 1, 2028, bears no interest (except upon default), and is convertible at US$1.62 per share beginning April 1, 2027. The warrant is exercisable immediately and expires on April 1, 2028.

- Advertisement -

In addition, the Company entered into an MOU with DL Holdings, outlining a proposed strategic cooperation framework. Under the MOU, DL Holdings has expressed its intention to make one or more strategic investments along with the Company, with an aggregate potential value of up to US$10 million. The contemplated investments are intended to support the Company’s initiatives in cryptocurrency mining facilities and AI.

- Advertisement -

These transactions are key steps in executing the Company’s previously disclosed financial strategy entering 2026: to strengthen its balance sheet, reduce leverage, and secure liquidity for its pivot toward AI infrastructure.

- Advertisement -

Contact: ir@cangoonline.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2933411/5896037/Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cango-inc-completes-us65-million-strategic-investment-and-secures-us10-million-convertible-note-financing-to-strengthen-financial-position-and-drive-ai-and-energy-expansion-302731674.html

- Advertisement -

Recent Posts

Stamus Networks Marks 10th Year Supporting NATO CCDCOE Cyber Defense Exercises

Company celebrates a decade of supporting the world's premier live-fire cyber defense exercises with expertise,…

44 minutes ago

argenx Presents New Efgartigimod Data Showing Long-Term Sustained Patient Benefit in Myositis and Sjogrens Disease at EULAR 2026

ALKIVIA+ data in myositis indicate efgartigimod provides sustained, clinically meaningful improvements and consistent safety RHO+…

3 hours ago

JJP Biologics Announces Positive Interim Phase 1b Data for Nebaprubart (JJP-1212), an Anti-CD89 Antagonist, in Linear IgA Disease (LAD)

Favorable safety and tolerability profile, with rapid onset of clinical activity and therapeutic effects observed…

3 hours ago

Johnson & Johnson late-breaking results show nipocalimab significantly reduced systemic lupus erythematosus (SLE) disease activity in a Phase 2 study

Nipocalimab – the first neonatal Fc receptor (FcRn) blocker to be studied in systemic lupus…

3 hours ago

GIGABYTE Unveils Next-Generation Gaming Peripherals with AORUS K10 INFINITY Keyboard and M10 INFINITY Mouse at COMPUTEX 2026

TAIPEI, June 3, 2026 /PRNewswire/ -- GIGABYTE, the world's leading computer brand, unveiled its next-generation…

3 hours ago

Nationwide Celebrations mark Ruskin Bond’s 92nd Birthday

GURUGRAM, India, June 2, 2026 /PRNewswire/ -- On May 19, 2026, 92 bookstores across India…

9 hours ago